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During the nine year period from June I, 1965 to June 
I, 1974, 69 patient s were treated with some type of 
Pelvic exenteration at the University of Michigan 
Medical Center. Total pelvic exenteration was per-
formed in over 75 % of the cases. The overall absolute 
~-Year survival rate was 60 %. The surgical mortality 
In the series reported was 1.5 %. The importance of 
various technical points to include "ski positioning" 
of the patient on the operating table, utilization of the 
transverse lower abdominal incision for operative ex-
Posure, development of a peritoneal graft to be used 
as a "diaphragm" at the level of the levator ani mu s-
cles, preparation of a ureterosigmoid conduit for uri -
~ary diversion and prophylactic compartmentaliza-
tion of the inferior vena cava are described. A split 
thickness skin graft vaginoplasty if de ired is per-
formed at a later date. 
INTRODUCTION 
For almost forty years all patients with gyneco-
logic malignancy referred to the Department 
of Obstetrics and Gynecology at the Uni-
versity of Michigan Medical Center have been 
Presented to the Gynecology Tumor Conference 
Which convenes twice weekly for final evaluation 
and outline of treatment. During the nine year 
PeriodfromJune I, 1965toJune I, 1974over2300 
Patients were presented to this conference and all 
f?rms of therapy were considered in the evalua-
tion of these patients. Approximately 82 % of the 
Patients were con idered for therapeutic man-
agement directed toward primary malignancie of 
-1 Presented (in part) at the VII World Congress of 
Gynecology and Obstetrics, Moscow, Russia, August 
16, 1973 . 
th e vulva, cervix, ut erus a nd ovary. These 
therapeutic mod alities included major or radical 
pelvic surgery, radiation therapy and/or chemo-
therapy as directed by the members of the Tu-
mor Board. Eighteen per cent of the total num-
ber of patients seen in the conference were eval-
uated for treatment of some type of recurrent 
gynecologic neoplas m . A major portion of thi s 
study was presented to the VII World Congress of 
Gynecology a nd Obstetrics in Moscow, Russia in 
August of 1973 . 
SELECTION OF CASES 
During this nine year (Jeriod, 418 or approximately 20 % 
of the patients were evaluated for recurrent or persis-
tent pelvic neoplasm subsequent to primary therapy . 
An additional 13 pati ents were evaluated for pelvic 
exenterative surge ry because of the extent and location 
of the disease; e.g., extensive ca rcinoma of the vulva. 
Of th e 431 patients, 213 or approximately 50 % of 
them were not con idered candidates for pelvic exen-
teration since the extent of the recurrence demon-
strated by evidence of distant metastasis outside of the 
pelvi s or by extent of the local pelvic process pre-
cluded surgical intervention . Radiation of pain because 
of sciatic nerve involvement, welling of one or both 
of the lower extremities caused by va cular or lym-
phatic permeation by tumor and signs of ureteral ob-
struction were considered contraindications to urgical 
exploration. Ureteral obstruction alone, however, was 
not considered a contraindication. 
Forty-three (10 %) patients had recu 1Tent ca rci noma 
of the ovary. The e patients were not considered candi-
dates for pelvic exenterative therapy si nce this condi-
tion when sufficiently ex tensive to be considered for 
thi s type of operation does not re pond well and it is 
therefore contraindicated. Another 65 (15 %) patient s 
were not co n idered candidates for surgery for th e 
following reasons: type and extent of other pelvic neo-
plasms; physical , mental and emotional status and re-
ligiou beliefs. Age of the patient per se, on rare occa-
sion, was considered the only contraindication for 
obvious reason . 
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Table I. Type of pelvic neoplasm 
Type Number Per cent 
Cervix 38 55.1 
Vagina 14 20.3 
Colon 7 10.2 
Vulva 5 7.1 
Uterus 4 5.8 
Urethra I 1.5 
Tota l 69 100 
110 patients (25 % ) were considered candidates for 
exploratory laparotomy to determine the resectability 
of the malignant neoplasm with therapeutic curability 
rather than palliation the ultimate goal. In a little more 
than 55% of these cases the primary diagnosis was 
recurrent carcinoma of the cervix (Table 1). Le ions of 
the vulva, vagina, uteru s, colon and urethra were also 
treated in this manner. Of the 110 patients who were 
explored 69 (63 %) of them proved to be candidates for 
some form of pe lvic exenteration. Fifty-four (78 %) of 
the patients in the operative series were treated with 
total pelvic exenteration. Eight ( 12 %) patients were 
treated with posterior pelvic exenteration and 7 (10 % ) 
patients were treated with anterior pelvic exenteration 
when the lesion was sufficiently loca lized to justify the 
less radical procedure. 
OPERATIVE METHOD 
In all cases, the preoperative treatment followed a 
standard regimen that included all related labora tory 
and X-ray examinations, appropriate consultations, 
bowel preparation and prophylac tic antibiotic therapy . 
Although routine antibiotic prophylaxis may be ques-
tionable in some types of surgery, it is generally ad visa-
Fig. I. "Ski position" utilized in pelvic exenteration 
with draping and incisions illustrated . 
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ble for procedures where contamination is likely as with 
the gastrointestinal and genitourinary tracts (1). 
In the operating room the patient is placed on the 
table in the "ski position" (Fig. I) which gives 
simultaneous access to the abdominal and perineal 
areas, not only for palpation of the lesion but also for the 
performance of the operative procedure itself. The 
abdominal ca vity is entered through a transverse inci-
sion with tran sect ion of the rectu s mu sc les bilatera lly . 
The transverse lower abdominal incision is considered 
the incision of choice since it provides increased ease of 
operability and the complications related to abdominal 
wounds are decreased significantly . 
Prior to the performa nce of the pelvic exenteration, 
the upper abdomen is explored thoroughly for evidence 
of metastatic disease, for if neoplasm is identified above 
the level of the pelvic brim, the procedure is terminated 
and the abdomen is closed . The pelvic contents are 
evaluated in a similar fa shion to determine the resecta-
bility of the lesion . As stated above, it is felt strongly 
that this operation with its subsequent prolonged re-
habilitation should not be undertaken as a palliative 
procedure . 
A peritonea l graft or nap (Fig. 2) to be used in the 
pelvic noor closure, if the radical resection is to be 
undertaken , is developed upon entrance into the ab-
dominal cavity (2). A tran sverse incision into the 
peritoneum is made approximately halfway between 
the trans-abdomina l incision and the level of the 
umbilicu s. The nap is further developed by a linea r 
incisio n of the peritoneum along the left la teral abdomi-
nal wall. The lower tran sverse inci sion of the peritoneal 
nap is made after the upper part of the bladder has been 
renected off the peritoneum and this incision is ex-
tended across to the right la teral abdominal wall where 
it remains attached in continuity or "hinged" for later 
use . The peritonea l nap measures approximately 8 by 
20cm . 
Fig. 2. Peritoneal graft prepared from anterior parietal 
Peritoneum. Used to cover the pelvic aperture. 
An en bloc dissection with removal of the female 
reproductive organs, the vagina, the distal third of the 
ureters, the bladder anteriorly and the bowel posterior-
Fig. 3. Peritoneal graft in place as a flap attached to the 
Pelvic aperture at the level of the pelvic diaphragm. 
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ly, when indicated, is then performed. The hypogastric 
arteries are ligated but not transected. The vulvar tis-
sues are not removed unless indicated by the extent or 
location of the disease. This allows for a better cosmetic 
result especiall y if one constructs a neovagina at a later 
date. 
Once the en bloc dissection has been completed and a 
bilateral pelvic lymph node dissection has been 
performed, the inferior vena cava is exposed on three 
sides at the level of L-4 and L-5 vertebra. By means of a 
Codman stapler the inferior vena cava is divided into 
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Table II. Postoperative complications 
Type 
Septicemia 
Bowel fistula 
Bladder fistula 
Small bowel prolapse (vaginal 
dehiscence) 
Intestinal obstruction• 
Pneumonitis 
Abdominal wound dehiscence 
Pulmonary embolization 
Others 
• Treated medically. 
Number 
15 
6 
4 
4 
12 
4 
2 
2 
7 
four compartments, as a prophylactic measure against 
major embolization. 
Some type of urinary diversion must be established if 
the bladder has been sacrificed. Currently, a uretero-
sigmoid conduit is considered the urinary diversion of 
choice when the total pelvic exenteration has been 
performed (3) . The uretero-sigmoid conduit has the 
advantage of rapidity and ease of performance, the 
avoidance of a small bowel anastomosis and hyper-
chloremic-hypokalemic acidosis is not a problem. 
Both ureters are mobilized and a mucosa-to-mucosa 
anastomosis to the anti-mesenteric border of a 10 to 12 
em isolated segment of distal sigmoid colon i 
performed. The proximal end of thi s isolated segment is 
closed and the distal end is brought out as an ostium 
through an incision placed midway between the 
umbilicus and the right anterior superior iliac spine . A 
sigmoid colostomy is then prepared in the usual manner 
with the ostium similarly placed in the left lower 
quadrant. The uretero-sigmoid conduit for uri·nary di-
ver ion was utilized in 49 patients who were treated 
with total pelvic exenteration. A uretero-ilealloop was 
used in the other five patients undergoing total pelvic 
exenteration a the urinary diversion . 
Before the abdominal wound is closed, the previously 
prepared peritoneal flap is attached peripherally at the 
level of the excised levator muscles of the pelvic dia-
phragm with interrupted silk sutures (Fig. 3). The 
perineal vault lying inferior to the peritoneal flap is 
packed in a routine manner. 
RESULTS 
In our series of 69 patients, 25 were operated 
upon five or · more years ago and 15 of these 
patients have survived and are clinically free of 
disease. The overall absolute 5-year survival rate 
is 60 %. Forty-two patients were operated three 
or more years ago and 25 of these patients are 
alive and clinically free of disease. The overall 
absolute 3-year survival rate is also 60 %. Only 
one of the 69 patients died during the first 30 days 
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after the operation . In this case , uncontrollable 
hemorrhage resulted in renal failure and death on 
the 22nd postoperative day. The surgical mortal-
ity in the series reported is 1.5 % . The hospital 
mortality is also 1.5 % . 
Since evidence of metastatic disease in the 
regional lymph nodes affords a very guarded 
prognosis, the results in such cases are of particu-
lar importance. In our group of 47 patients treated 
2 or more years ago, eight had lymph node in-
volvement and all of these patients have died ; 
whereas, 29 of the 39 patients without lymph node 
involvement are alive and clinically free of dis-
ease at the present time. 
The ages of the patients in this series ranged 
from 33 to 70 years with a median of 53 . The 
average time required for operation wa 5 hours 
and 45 minutes and the median estimated blood 
loss per patient was 2 800 mi. The median length 
of hospital stay was 30 days. 
Significant complications developed in about 
one-third of the cases in this series (Table II); 
however, specific treatment for these complica-
tions was successful in most instances. Septi-
cemia remains the most common postoperative 
complication; it is usually associated with an 
acute urinary tract infection. In fifteen patients , 
further operations were necessary to correct 
fistulas of the bowel or bladder; to close a wound 
dehiscence; to improve urinary diversion or to 
determine whether the neoplastic disease had re-
curred. No urinary fistulae and only .two small 
bowel fistulae have occurred in the last 42 pa-
tients. The two fistulae were secondary to per-
sistent and longstanding pelvic abscess. 
Fig . 4. Illustration of split-thickness skin graft taken 
from posterior surface of thigh and applied to granula-
tion bed in the perineal vault as a neo-vagina. 
DISCUSSION 
In our institution the multi-disciplinary approach 
to pelvic exenteration, which includes a gyneco-
logist and a general surgeon, has been sup-
ported. The responsibility for the conduct of the 
operative procedure is alternated between the 
gynecologist and the general surgeon . These two 
members of the team are present throughout all 
Procedures and alternate as first assis tant. Fre-
quently during the procedure both members of 
the team work simultaneously in operating 
trans-vaginall y and transabdominally as well as in 
Preparation of the abdominal stomata. 
Pathologi sts emphas ize that les ions of the 
squamous cell variety tend to grow along the 
Planes of leas t res istance and in continuity into 
s~rrounding ti ssues for some time before they 
enher involve adjacent vital structures or 
meta tasize di stantly. The prime indication for 
Pelvic exenteration, therefore, is recurrent or 
Persistent carcinoma of the cervix both because 
of its overall incidence and its growth pattern . 
Essentially all patients with previously untreated 
carcinoma of the cervix, however , are not consi-
dered candidates for pelvic exenteration, ir-
re pective of stage of di sease, but are managed by 
more conventional means at the present time . 
As stated earlier, the peritoneal fl ap or graft i 
Utili zed as a "diaphragm" at the level of the 
levator ani muscles and it divides the large de-
nuded cavity into two compartments acting 
simultaneously as a floor for the intra-abdominal 
contents and a roof for the perineal vault which 
Ultimately becomes a neo-vagina in those cases 
where pia tic reconstruction i to be considered. 
The utilization of the peritoneal graft has de-
creased the postoperative morbidity significantly 
and we prefer this method of closure of the pelvic 
aperture to all other method previously recom-
mended (4, 5). A number of these patients have 
been re-operated for various rea ons and to date 
We have not encountered a contraindication to 
thi method of pelvic compartmentalization. 
Some time later vaginal reconstruction (Fig. 4) 
Utilizing a split-thickness skin graft is considered 
for those patients whose sexual rehabilitation is a 
matter of concern (6) . Twenty patients were 
treated in this fashion from 3 to 6 weeks following 
the pelvic exenteration. Once a satisfactory 
granulation bed has been established in the pelvic 
vault and the peri neal defect has decreased to the 
size of a normal vagina, a split-thickness skin 
?raft usually taken from the posterior thigh region 
ts u ed to " line" the defect in preparation of a 
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neo-vagina. The operation was performed with-
out difficulty in all instances, and in no cases was 
excessive bleeding a problem. Other than dis-
comfort at the donor graft site , no serious compli-
cations were encountered in the postoperative 
period and the functional results have been 
gratifying. The postoperative rehabilitation was 
significantly improved for these individuals, 
however, not all patients subjected to exentera-
tive therapy are candidates for vaginoplasty ; for 
reasons of age, marital status and personal incli-
nation . 
Finally, the surgeon who embarks on a pro-
gram of pelvic exenterative therapy must be 
ready to accept increased responsibility, not 
only for the significant operative risk, the criti-
cal and extensive problems of postoperative 
care but also for the long term rehabilitation 
of the patient. On the other hand, the rewards 
are gratifying-pelvic exenteration does afford 
the patient a second chance at survival and those 
who have been cured are able to lead active 
and rewarding lives. 
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